BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29784750)

  • 1. Pregnancy in Patients With Chronic Myeloid Leukemia.
    Berman E
    J Natl Compr Canc Netw; 2018 May; 16(5S):660-662. PubMed ID: 29784750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy: part of life in chronic myelogenous leukemia.
    Law AD; Dong Hwan Kim D; Lipton JH
    Leuk Lymphoma; 2017 Feb; 58(2):280-287. PubMed ID: 27389567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study.
    Conchon M; Sanabani SS; Bendit I; Santos FM; Serpa M; Dorliac-Llacer PE
    J Hematol Oncol; 2009 Oct; 2():42. PubMed ID: 19807918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of chronic myelogenous leukemia in pregnancy.
    Bhandari A; Rolen K; Shah BK
    Anticancer Res; 2015 Jan; 35(1):1-11. PubMed ID: 25550528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Myelogenous Leukemia: Pregnancy in the Era of Stopping Tyrosine Kinase Inhibitor Therapy.
    Berman E; Druker BJ; Burwick R
    J Clin Oncol; 2018 Apr; 36(12):1250-1256. PubMed ID: 29447062
    [No Abstract]   [Full Text] [Related]  

  • 6. NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.
    Pallera A; Altman JK; Berman E; Abboud CN; Bhatnagar B; Curtin P; DeAngelo DJ; Gotlib J; Hagelstrom RT; Hobbs G; Jagasia M; Kantarjian HM; Kropf P; Metheny L; Moore JO; Ontiveros E; Purev E; Quiery A; Reddy VV; Rose MG; Shah NP; Smith BD; Snyder DS; Sweet KL; Tibes R; Yang DT; Gregory K; Sundar H; Deininger M; Radich JP
    J Natl Compr Canc Netw; 2016 Dec; 14(12):1505-1512. PubMed ID: 27956535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports.
    Alizadeh H; Jaafar H; Kajtár B
    Ann Saudi Med; 2015; 35(6):468-71. PubMed ID: 26657232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dramatic fetal outcome following transplacental transfer of dasatinib.
    Berveiller P; Andreoli A; Mir O; Anselem O; Delezoide AL; Sauvageon H; Chapuis N; Tsatsaris V
    Anticancer Drugs; 2012 Aug; 23(7):754-7. PubMed ID: 22421368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib.
    Hermel DJ; Chiu V; Hermel MH; Tulpule A; Akhtari M
    J Oncol Pharm Pract; 2019 Apr; 25(3):699-702. PubMed ID: 29207935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon-alpha in 1st trimester: report of 3 cases and review of the literature.
    Mubarak AA; Kakil IR; Awidi A; Al-Homsi U; Fawzi Z; Kelta M; Al-Hassan A
    Am J Hematol; 2002 Feb; 69(2):115-8. PubMed ID: 11835347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing pregnancy in chronic myeloid leukaemia.
    Palani R; Milojkovic D; Apperley JF
    Ann Hematol; 2015 Apr; 94 Suppl 2():S167-76. PubMed ID: 25814083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing women of childbearing age with chronic myeloid leukemia: safety and treatment considerations.
    Robertson HF; Buckton MJ; Apperley JF
    Expert Rev Hematol; 2023 May; 16(5):325-332. PubMed ID: 37038615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of pregnancy in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors: short report from a single centre.
    Alizadeh H; Jaafar H; Rajnics P; Khan MI; Kajtár B
    Leuk Res; 2015 Jan; 39(1):47-51. PubMed ID: 25455655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis about the management and the perinatal outcomes of pregnancy with chronic myeloid leukemia].
    Wang DP; Liang MY; Zhang XH; Wang SM
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):735-9. PubMed ID: 21176552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myeloid leukemia with pregnancy: Successful management of pregnancy and delivery with hydroxyurea and imatinib continued till delivery.
    Yadav U; Solanki SL; Yadav R
    J Cancer Res Ther; 2013; 9(3):484-6. PubMed ID: 24125987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea treatment for chronic myeloid leukaemia during pregnancy.
    Jackson N; Shukri A; Ali K
    Br J Haematol; 1993 Sep; 85(1):203-4. PubMed ID: 8251394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pregnancy on the outcomes of childbearing age women with chronic myeloid leukemia.
    Santos FM; Ghelfond G; Seguro FS; Abdo ANR; Dalessandro T; Maciel FVR; Bassolli L; Rocha V; Bendit I
    Am J Hematol; 2022 Feb; 97(2):E72-E74. PubMed ID: 34822180
    [No Abstract]   [Full Text] [Related]  

  • 18. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy in a patient receiving busulphan for chronic myeloid leukaemia.
    Norhaya MR; Cheong SK; Hamidah NH; Ainoon O
    Singapore Med J; 1994 Feb; 35(1):102-3. PubMed ID: 8009265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukaemia in pregnancy: call for guidelines.
    P P; Samal R; Ghose S
    J Obstet Gynaecol; 2019 May; 39(4):582-583. PubMed ID: 30744447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.